Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
FMC provided 2025 revenue guidance of $4.15 billion to $4.35 billion, flat at the midpoint compared to 2024, excluding the impact of the Global Specialty Solutions (GSS) divestiture. Adjusted EPS ...
Tim Boyle, CEO, highlighted the company's return to growth in North America and continued momentum in international markets. He noted inventory reduction by 7% and highlighted the success of the ...